Viewing Study NCT04459702


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-01-04 @ 4:49 PM
Study NCT ID: NCT04459702
Status: WITHDRAWN
Last Update Posted: 2021-04-08
First Post: 2020-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Combination Therapies to Treat COVID-19 Infection
Sponsor: ProgenaBiome
Organization:

Study Overview

Official Title: A Phase IIa Randomized, Controlled Study of Combination Therapies to Treat COVID-19 Infection
Status: WITHDRAWN
Status Verified Date: 2021-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Was never started
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study seeks to determine whether dual or quadruple therapy is more effective in treating COVID-19.
Detailed Description: In this study, patients will be administered either dual or quadruple therapy and have PCR tests run daily to determine efficacy as indicated by time to non-infectivity

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: